TD Asset Management Inc decreased its position in The Clorox Company (NYSE:CLX – Free Report) by 31.9% during the 2nd quarter, Holdings Channel reports. The firm owned 123,453 shares of the company’s stock after selling 57,702 shares during the quarter. TD Asset Management Inc’s holdings in Clorox were worth $14,823,000 at the end of the most recent reporting period.
Several other large investors have also made changes to their positions in CLX. Hsbc Holdings PLC grew its holdings in shares of Clorox by 118.8% in the 1st quarter. Hsbc Holdings PLC now owns 1,085,661 shares of the company’s stock worth $159,699,000 after purchasing an additional 589,544 shares during the last quarter. Robeco Institutional Asset Management B.V. lifted its position in Clorox by 101.8% during the 2nd quarter. Robeco Institutional Asset Management B.V. now owns 1,083,723 shares of the company’s stock worth $130,123,000 after buying an additional 546,761 shares in the last quarter. KBC Group NV lifted its position in Clorox by 688.7% during the 1st quarter. KBC Group NV now owns 587,679 shares of the company’s stock worth $86,535,000 after buying an additional 513,171 shares in the last quarter. AQR Capital Management LLC lifted its position in Clorox by 412.1% during the 1st quarter. AQR Capital Management LLC now owns 598,758 shares of the company’s stock worth $88,167,000 after buying an additional 481,846 shares in the last quarter. Finally, Goldman Sachs Group Inc. lifted its position in Clorox by 147.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 707,005 shares of the company’s stock worth $104,107,000 after buying an additional 421,453 shares in the last quarter. Institutional investors own 78.53% of the company’s stock.
Analyst Ratings Changes
CLX has been the topic of several research reports. Jefferies Financial Group reduced their price target on shares of Clorox from $167.00 to $145.00 and set a “buy” rating on the stock in a research report on Thursday, June 26th. Citigroup reduced their price target on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. UBS Group reduced their price target on shares of Clorox from $134.00 to $128.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Deutsche Bank Aktiengesellschaft reduced their price target on shares of Clorox from $135.00 to $128.00 and set a “hold” rating on the stock in a research report on Monday, October 13th. Finally, Barclays reduced their price target on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $130.20.
Clorox Stock Performance
Clorox stock opened at $119.73 on Friday. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The company has a market cap of $14.58 billion, a PE ratio of 18.36, a PEG ratio of 0.99 and a beta of 0.52. The company’s 50-day moving average is $121.61 and its two-hundred day moving average is $127.73.
Clorox (NYSE:CLX – Get Free Report) last released its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $1.94 billion. During the same period in the prior year, the company posted $1.82 EPS. The company’s revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities analysts anticipate that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be given a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio (DPR) is currently 76.07%.
Insider Buying and Selling at Clorox
In related news, COO Eric H. Reynolds sold 15,041 shares of the stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer directly owned 54,221 shares in the company, valued at $6,711,475.38. This trade represents a 21.72% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.63% of the stock is owned by corporate insiders.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- What is a penny stock? A comprehensive guide
- Johnson & Johnson’s M&A Strategy Is the Real Story for Investors
- What Are the U.K. Market Holidays? How to Invest and Trade
- Tesla: Some Analysts Are Calling for A 30% Drop—Time to Panic?
- What Are Growth Stocks and Investing in Them
- Hedge Funds Flip on the Dollar—A Buy Signal for These 3 Stocks?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
